Related Experiment Videos
[Multiple endocrine neoplasia type 2]
Ana Luiza Maia1, Jorge Luiz Gross, Marcia Khaled Puñales
1Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS. almaia@ufrgs.br
Arquivos Brasileiros De Endocrinologia E Metabologia
|January 31, 2006
Summary
Multiple Endocrine Neoplasia (MEN) type 2 involves endocrine tumors, primarily medullary thyroid carcinoma. Early genetic screening and intervention improve outcomes, but disseminated disease remains challenging to treat.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple Endocrine Neoplasia (MEN) encompasses inherited endocrine tumor syndromes.
- MEN type 2 (MEN 2) is characterized by medullary thyroid carcinoma (MTC), often the initial diagnosis.
- MEN 2 comprises MEN 2A (MTC, pheochromocytoma, hyperparathyroidism) and MEN 2B (MTC, mucosal neuromas, specific physical features).
Purpose of the Study:
- To review the pathological characteristics, genetic abnormalities, and clinical features of MEN 2.
- To outline diagnostic and therapeutic strategies for patients with MEN 2 and carriers.
- To highlight the impact of genetic screening and early intervention on patient outcomes.
Main Methods:
- Review of pathological, genetic, and clinical data for MEN 2.
- Discussion of diagnostic criteria and screening protocols.
- Analysis of therapeutic approaches and their effectiveness.
Main Results:
- Medullary thyroid carcinoma (MTC) is a hallmark of MEN 2, necessitating comprehensive evaluation.
- RET proto-oncogene analysis is crucial for distinguishing sporadic from hereditary MTC and identifying carriers.
- Advances in genetic screening and early intervention have improved long-term prognosis for MEN 2 patients.
Conclusions:
- Early diagnosis and management of MEN 2, particularly through genetic screening, significantly enhance patient outcomes.
- While progress has been made, effective treatments for advanced or disseminated MEN 2 disease are still lacking.